Company
Cleerly Health
Cleerly’s AI-enabled CCTA solution provides comprehensive, accurate, and trackable insights to personalize heart attack prevention.
Also known as Cleerly, Cleerly, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- PAYORS & PROVIDERS
- Legal name
- Cleerly, Inc.
- cleerlyhealth.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution.
Funding snapshot
- Total raised
- $275MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $51.3M2024-11-19
Funding rounds
- Round, 2024
- $51.3M2024-11-19, SEC form D sold, 10 investors
- Round, 2022
- $192M2022-07-08, SEC form D sold, 56 investors
- Round, 2022
- $16.8M2022-02-25, SEC form D sold, 25 investors
- Round, 2017
- $14.5M2017-07-31, SEC form D sold, 31 investors
Products
- Web
- Cleerly ISCHEMIA
- Web
- Cleerly Labs
Loading relationship preview